Similar to other trials noting improved survival for the HPV+ HNSCC cohort, Heiduschka et al. showed improved survival for the patients both p16-positive and HPV DNA ISH-positive after surgery and adjuvant radiation [138]. Here, CDKN2A is linked to head and neck squamous cell carcinoma.